Teleflex Incorporated (NYSE:TFX) Shares Sold by Citizens Financial Group Inc. RI

Citizens Financial Group Inc. RI reduced its position in Teleflex Incorporated (NYSE:TFX) by 45.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,174 shares of the medical technology company’s stock after selling 964 shares during the quarter. Citizens Financial Group Inc. RI’s holdings in Teleflex were worth $209,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in TFX. Marathon Trading Investment Management LLC acquired a new position in shares of Teleflex in the 4th quarter valued at about $1,211,000. Daiwa Securities Group Inc. raised its holdings in Teleflex by 3.4% in the fourth quarter. Daiwa Securities Group Inc. now owns 11,674 shares of the medical technology company’s stock valued at $2,077,000 after buying an additional 379 shares during the period. Isthmus Partners LLC raised its holdings in Teleflex by 7.3% in the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company’s stock valued at $273,000 after buying an additional 105 shares during the period. Amundi lifted its position in Teleflex by 10.3% during the fourth quarter. Amundi now owns 389,876 shares of the medical technology company’s stock valued at $69,382,000 after buying an additional 36,299 shares in the last quarter. Finally, Machina Capital S.A.S. increased its position in shares of Teleflex by 161.5% in the fourth quarter. Machina Capital S.A.S. now owns 2,597 shares of the medical technology company’s stock worth $462,000 after acquiring an additional 1,604 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Stock Up 1.1 %

NYSE:TFX opened at $137.79 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The company has a market capitalization of $6.39 billion, a price-to-earnings ratio of 27.39, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a one year low of $128.55 and a one year high of $249.90. The stock has a 50-day simple moving average of $166.99 and a 200 day simple moving average of $197.99.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. The company had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Sell-side analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 0.99%. Teleflex’s payout ratio is 95.77%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on TFX. Bank of America lowered Teleflex from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $235.00 to $140.00 in a research note on Tuesday, March 4th. Piper Sandler reissued a “neutral” rating and set a $140.00 target price (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Royal Bank of Canada lowered shares of Teleflex from an “outperform” rating to a “sector perform” rating and lowered their price target for the company from $220.00 to $155.00 in a report on Friday, February 28th. Citizens Jmp cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. Finally, Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Teleflex has a consensus rating of “Hold” and a consensus target price of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.